FLAG Therapeutics, Inc. Email Format

Pharmaceutical ManufacturingNorth Carolina, United States2-10 Employees

FLAG Therapeutics is an early-stage pharmaceutical company focused on oncology, headquartered in Raleigh, North Carolina. It is developing two novel classes of small molecule, water-soluble drugs with in vivo studies suggesting potential advantages in safety and efficacy over conventional therapies, including antiangiogenic/anti-tubulin and folate-targeted anti-cancer compounds. The company has secured exclusive worldwide rights to these compounds from Duquesne University, and its work targets multiple cancer types with the aim of providing new therapeutic options. FLAG Therapeutics operates within the pharmaceutical manufacturing industry, positioning itself as a research-driven entity advancing small molecule therapies through initial development stages from its Raleigh base. The organization is characterized as a small company in the early stages, reflecting its nascency and focus on advancing its proprietary oncology programs from a regional hub in North Carolina.

Get verified FLAG Therapeutics, Inc. emails free

Company overview Employee directory